These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

163 related articles for article (PubMed ID: 39197909)

  • 41. The effects of checkpoint inhibition on head and neck squamous cell carcinoma: A systematic review.
    Ghanizada M; Jakobsen KK; Grønhøj C; von Buchwald C
    Oral Oncol; 2019 Mar; 90():67-73. PubMed ID: 30846179
    [TBL] [Abstract][Full Text] [Related]  

  • 42. The Geriatric Nutritional Risk Index (GNRI) as a Prognostic Biomarker for Immune Checkpoint Inhibitor Response in Recurrent and/or Metastatic Head and Neck Cancer.
    Haas M; Lein A; Fuereder T; Brkic FF; Schnoell J; Liu DT; Kadletz-Wanke L; Heiduschka G; Jank BJ
    Nutrients; 2023 Feb; 15(4):. PubMed ID: 36839241
    [TBL] [Abstract][Full Text] [Related]  

  • 43. Post-treatment Neutrophil/Lymphocyte Ratio Is a Prognostic Factor in Head and Neck Cancers Treated With Nivolumab.
    Iwasa YI; Kitoh R; Yokota Y; Hori K; Kasuga M; Kobayashi T; Kanda S; Takumi Y
    Cancer Diagn Progn; 2024; 4(2):182-188. PubMed ID: 38434918
    [TBL] [Abstract][Full Text] [Related]  

  • 44. The prognostic value of preoperative laboratory data indicators in patients with esophageal carcinoma: An observational study.
    Ma H; Liu Y; Ye H; Gao F; Li Z; Qin S
    Medicine (Baltimore); 2024 Jun; 103(24):e38477. PubMed ID: 38875403
    [TBL] [Abstract][Full Text] [Related]  

  • 45. Prognostic value of inflammatory markers and clinical features for survival in advanced or metastatic esophageal squamous cell carcinoma patients receiving anti-programmed death 1 treatment.
    Da L; Qu Z; Zhang C; Shen Y; Huang W; Zhang Y; Gu K
    Front Oncol; 2023; 13():1144875. PubMed ID: 37035159
    [TBL] [Abstract][Full Text] [Related]  

  • 46. Combining dynamics of serum inflammatory and nutritional indicators as novel biomarkers in immune checkpoint inhibitor treatment of non-small-cell lung cancer with bone metastases.
    Asano Y; Hayashi K; Takeuchi A; Kato S; Miwa S; Taniguchi Y; Okuda M; Matsumoto I; Yano S; Demura S
    Int Immunopharmacol; 2024 Jul; 136():112276. PubMed ID: 38820958
    [TBL] [Abstract][Full Text] [Related]  

  • 47. Systemic immune-inflammation index predicting chemoradiation resistance and poor outcome in patients with stage III non-small cell lung cancer.
    Tong YS; Tan J; Zhou XL; Song YQ; Song YJ
    J Transl Med; 2017 Oct; 15(1):221. PubMed ID: 29089030
    [TBL] [Abstract][Full Text] [Related]  

  • 48. Post-treatment neutrophil-to-lymphocyte ratio (NLR) predicts response to anti-PD-1/PD-L1 antibody in SCLC patients at early phase.
    Xiong Q; Huang Z; Xin L; Qin B; Zhao X; Zhang J; Shi W; Yang B; Zhang G; Hu Y
    Cancer Immunol Immunother; 2021 Mar; 70(3):713-720. PubMed ID: 32910245
    [TBL] [Abstract][Full Text] [Related]  

  • 49. The role of CD73 in predicting the response to immunotherapy in head and neck cancer patients.
    Botticelli A; Cirillo A; d'Amati G; Di Gioia C; Corsi A; Della Rocca C; Santini D; Carletti R; Pisano A; Polimeni A; De Vincentiis M; Valentini V; di Cristofano C; Romeo U; Cerbelli E; Messineo D; De Felice F; Leopizzi M; Cerbelli B
    Pathol Res Pract; 2024 Aug; 260():155415. PubMed ID: 38996615
    [TBL] [Abstract][Full Text] [Related]  

  • 50. A novel and accurate predictor of survival for patients with hepatocellular carcinoma after surgical resection: the neutrophil to lymphocyte ratio (NLR) combined with the aspartate aminotransferase/platelet count ratio index (APRI).
    Ji F; Liang Y; Fu SJ; Guo ZY; Shu M; Shen SL; Li SQ; Peng BG; Liang LJ; Hua YP
    BMC Cancer; 2016 Feb; 16():137. PubMed ID: 26907597
    [TBL] [Abstract][Full Text] [Related]  

  • 51. Nomogram based on pre-treatment inflammatory biomarkers predicting survival in patients with head and neck soft tissue sarcoma.
    Chen L; Zeng H; Du Z; Zhao Y; Ma X
    Cancer Biomark; 2020; 29(1):151-161. PubMed ID: 32623392
    [TBL] [Abstract][Full Text] [Related]  

  • 52. Inflammation-based indexes and clinicopathologic features are strong predictive values of preoperative circulating tumor cell detection in gastric cancer patients.
    Zheng L; Zou K; Yang C; Chen F; Guo T; Xiong B
    Clin Transl Oncol; 2017 Sep; 19(9):1125-1132. PubMed ID: 28315180
    [TBL] [Abstract][Full Text] [Related]  

  • 53. Correlation between preoperative peripheral blood NLR, PLR, LMR and prognosis of patients with head and neck squamous cell carcinoma.
    Zhou J; Wei S; Guo X; Huang Y; Zhang Y; Hong Y; Chen X; Lu M; Zheng F; Zheng C
    BMC Cancer; 2023 Dec; 23(1):1247. PubMed ID: 38110870
    [TBL] [Abstract][Full Text] [Related]  

  • 54. The Evolving Landscape of PD-1/PD-L1 Pathway in Head and Neck Cancer.
    Qiao XW; Jiang J; Pang X; Huang MC; Tang YJ; Liang XH; Tang YL
    Front Immunol; 2020; 11():1721. PubMed ID: 33072064
    [TBL] [Abstract][Full Text] [Related]  

  • 55. Systemic Inflammation Indexes and Risk of Immune-related Adverse Events in Patients With Metastatic Urothelial Carcinoma Treated With Immunotherapy.
    Dionese M; Bimbatti D; Pierantoni F; Lai E; Erbetta E; Cavasin N; Jubran S; Basso U; Maruzzo M
    Anticancer Res; 2024 Oct; 44(10):4379-4386. PubMed ID: 39348984
    [TBL] [Abstract][Full Text] [Related]  

  • 56. Clinical significance of prognostic nutritional index (PNI) in malignant melanoma.
    Mirili C; Yılmaz A; Demirkan S; Bilici M; Basol Tekin S
    Int J Clin Oncol; 2019 Oct; 24(10):1301-1310. PubMed ID: 31073814
    [TBL] [Abstract][Full Text] [Related]  

  • 57. Prognostic significance of prognostic nutritional index and systemic immune-inflammation index in patients after curative breast cancer resection: a retrospective cohort study.
    Xu T; Zhang SM; Wu HM; Wen XM; Qiu DQ; Yang YY; Wang LZ; Zhu WB; He LS; Li JJ
    BMC Cancer; 2022 Nov; 22(1):1128. PubMed ID: 36329394
    [TBL] [Abstract][Full Text] [Related]  

  • 58. Neutrophil-lymphocyte ratio, platelet-lymphocyte ratio, neutrophil-platelet score and prognostic nutritional index: do they have prognostic significance in metastatic pancreas cancer?
    Dogan M; Algin E; Guven ZT; Baykara M; Kos TF; Bal O; Zengin N
    Curr Med Res Opin; 2018 May; 34(5):857-863. PubMed ID: 29161926
    [TBL] [Abstract][Full Text] [Related]  

  • 59. Prognostic role of programmed cell death ligand-1 expression in head and neck cancer treated with programmed cell death protein-1/programmed cell death ligand-1 inhibitors: A meta-analysis based on clinical trials.
    Huang Z; Zheng S; Ding S; Wei Y; Chen C; Liu X; Li H; Xia Y
    J Cancer Res Ther; 2021 Jul; 17(3):676-687. PubMed ID: 34269299
    [TBL] [Abstract][Full Text] [Related]  

  • 60. High neutrophil-to-lymphocyte ratio predicts poor prognosis in patients with squamous cell carcinoma of the head and neck treated with definitive chemoradiotherapy.
    Chandrasekara S; Davis S; Thomson P; Haydon A
    Asia Pac J Clin Oncol; 2018 Oct; 14(5):e442-e447. PubMed ID: 29345108
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 9.